Huot P - Search Results

1

L-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease.

Huot P, Johnston TH, Koprich JB, Fox SH, Brotchie JM. Huot P, et al. Neuropharmacology. 2012 Oct;63(5):829-36. doi: 10.1016/j.neuropharm.2012.06.012. Epub 2012 Jun 18. Neuropharmacology. 2012. PMID: 22722022

2

Anticonvulsant Agents for Treatment of Restless Legs Syndrome: A Case Report With Lamotrigine and a Review of the Literature.

Al-Kassmy J, Alsalmi M, Kang W, Huot P. Al-Kassmy J, et al. Among authors: huot p. Neurologist. 2024 May 1;29(3):173-178. doi: 10.1097/NRL.0000000000000552. Neurologist. 2024. PMID: 38250816 Review.

3

Activation of mGlu 2/3 receptors with the orthosteric agonist LY-404,039 alleviates dyskinesia in experimental parkinsonism.

Kang W, Frouni I, Kwan C, Desbiens L, Hamadjida A, Huot P. Kang W, et al. Among authors: huot p. Behav Pharmacol. 2024 Jun 1;35(4):185-192. doi: 10.1097/FBP.0000000000000765. Epub 2024 Mar 29. Behav Pharmacol. 2024. PMID: 38563661

4

A discussion with Philippe Huot: the challenges of discovering novel therapies for the treatment of Parkinson's disease.

Huot P. Huot P. Neurodegener Dis Manag. 2024;14(5):127-129. doi: 10.1080/17582024.2024.2389034. Epub 2024 Aug 19. Neurodegener Dis Manag. 2024. PMID: 39161200 No abstract available.

5

Pharmacokinetic profile of bitopertin, a selective GlyT₁ inhibitor, in the rat.

Frouni I, Bédard D, Bourgeois-Cayer É, Hamadjida A, Gaudette F, Beaudry F, Huot P. Frouni I, et al. Among authors: huot p. Naunyn Schmiedebergs Arch Pharmacol. 2023 May;396(5):1053-1060. doi: 10.1007/s00210-022-02378-1. Epub 2023 Jan 12. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36633618

6

Levodopa-induced dyskinesia: do current clinical trials hold hope for future treatment?

Alsalmi M, Al-Kassmy J, Kang W, Palayew M, Huot P. Alsalmi M, et al. Among authors: huot p. Expert Opin Pharmacother. 2024 Jan-Apr;25(1):1-3. doi: 10.1080/14656566.2023.2298345. Epub 2024 Feb 1. Expert Opin Pharmacother. 2024. PMID: 38116733 No abstract available.

7

Metronidazole-induced encephalopathy in a patient with cirrhosis.

Ji X, Li KX, Freitas LF, Huot P. Ji X, et al. Among authors: huot p. Radiol Case Rep. 2023 Oct 28;19(1):126-129. doi: 10.1016/j.radcr.2023.10.001. eCollection 2024 Jan. Radiol Case Rep. 2023. PMID: 37941988 Free PMC article.

8

Targeting metabotropic glutamate receptors for the treatment of Parkinson's disease.

Huot P. Huot P. Neurodegener Dis Manag. 2023 Aug;13(4):203-206. doi: 10.2217/nmt-2023-0016. Epub 2023 Jun 12. Neurodegener Dis Manag. 2023. PMID: 37306283 No abstract available.

9

New insights into the organization of the basal ganglia.

Koprich JB, Johnston TH, Huot P, Fox SH, Brotchie JM. Koprich JB, et al. Among authors: huot p. Curr Neurol Neurosci Rep. 2009 Jul;9(4):298-304. doi: 10.1007/s11910-009-0045-2. Curr Neurol Neurosci Rep. 2009. PMID: 19515282

10

Neuropsychiatric behaviors in the MPTP marmoset model of Parkinson's disease.

Fox SH, Visanji N, Reyes G, Huot P, Gomez-Ramirez J, Johnston T, Brotchie JM. Fox SH, et al. Among authors: huot p. Can J Neurol Sci. 2010 Jan;37(1):86-95. doi: 10.1017/s0317167100009707. Can J Neurol Sci. 2010. PMID: 20169779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters